Dr. McNamara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
New Haven, CT 06510Phone+1 203-785-5188Fax+1 203-785-5163
Education & Training
- University of California (San Francisco)Residency, Obstetrics and Gynecology, 2018 - 2022
- Yale School of MedicineClass of 2018
Certifications & Licensure
- CT State Medical License 2022 - 2025
- CA State Medical License 2019 - 2023
Publications & Presentations
PubMed
- Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovaria...Levent Mutlu, Blair McNamara, Stefania Bellone, Diego D Manavella, Cem Demirkiran
Clinical & Experimental Metastasis. 2024-10-01 - Unmet needs in cervical cancer - can biological therapies plug the gap?Michelle Greenman, Yifan Emily Chang, Blair McNamara, Levent Mutlu, Alessandro D Santin
Expert Opinion on Biological Therapy. 2024-10-01 - Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma.Blair McNamara, Michelle Greenman, Stefania Bellone, Luca A Santin, Cem Demirkiran
Gynecologic Oncology. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: